CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
1.480
+0.060 (4.23%)
Jul 25, 2025, 4:00 PM - Market closed
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $22.93 million as of July 25, 2025. Its market cap has decreased by -72.93% in one year.
Market Cap
22.93M
Enterprise Value
28.72M
1-Year Change
-72.93%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from $101.76M to $22.93M, a decrease of -77.47%. That is a compound annual growth rate of -4.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2025 | 22.93M | -47.70% |
Dec 31, 2024 | 43.84M | -54.03% |
Dec 29, 2023 | 95.38M | 291.63% |
Dec 30, 2022 | 24.35M | -78.22% |
Dec 31, 2021 | 111.84M | -69.41% |
Dec 31, 2020 | 365.63M | 22.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 723.06B |
Johnson & Johnson | 407.97B |
AbbVie | 337.08B |
Novo Nordisk | 313.06B |
UnitedHealth Group | 252.71B |
AstraZeneca | 228.91B |
Novartis AG | 227.81B |
Abbott Laboratories | 218.59B |